4//SEC Filing
John Minardo 4
Accession 0000950170-25-019234
CIK 0001446847other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 9:00 PM ET
Size
18.0 KB
Accession
0000950170-25-019234
Insider Transaction Report
Form 4
John Minardo
Chief Legal Officer
Transactions
- Sale
Class A Common Stock
2025-02-10$1.76/sh−38,938$68,531→ 408,132 total - Award
Class A Common Stock
2025-02-10+122,222→ 447,070 total
Footnotes (3)
- [F1]The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.
- [F2]The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units and performance-based restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.60 to $1.84, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
IRONWOOD PHARMACEUTICALS INC
CIK 0001446847
Entity typeother
Related Parties
1- filerCIK 0001875067
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 9:00 PM ET
- Size
- 18.0 KB